Tweets
When you're the boss, "reasons don't matter...success or failure is totally within your control"
- Steve Jobs https://t.co/5rDanu7Oj4
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Estimated 795 000 Americans are misdiagnosed annually (371,000 pts die; 424,000 permanently disabled). Just 15 diseases account for about half of all serious harms & top 5 (Stroke, Sepsis, Pneumonia, VTE, Lung CA) account for 39% https://t.co/3pvgGLLHbs https://t.co/94ij9txIyK
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Structured interviews from 462 pts from Michigan SLE clinic. 22% admit to cost-related non-adherence (CRNA) over 12 mos. CRNA associated signif. higher levels SLE disease activity & more lupus damage. Worse scores in those with Fibromyalgia https://t.co/NHIIqmWVqJ https://t.co/zX4gTFTcW7
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Adding Trabecular Bone Score (TBS) to FRAX and BMD enhances Fx risk prediction in osteoporosis. TBS is validated index of bone microarchitecture from LS spine DEXA. TBS is good at fragility Fx risk and monitoring response to OP Rx https://t.co/T7EStHyDBq https://t.co/sct79nTzBO
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
CMS billing data shows female MDs are 25% more likely than male MDs to leave academia (OR 1.25; 1.23-1.28); at all stages of their careers. At 5 yrs, attrition rate from academia was 34.2% (38.3% for females and 32.4% for male physicians). https://t.co/5wZKuYrdoB https://t.co/wNPGOCDSJ4
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
SGLT2 Inhibitors Reduce Gout Flares and CV Events
A cohort analysis shows that gout patients initiating sodium–glucose cotransporter-2 inhibitors (SGLT2is) had lower serum urate levels and fewer gouty flares requiring ED visits or hospitalizations.
https://t.co/fmz1j6pHgL https://t.co/XbqWxZRd97
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
US study shows 1635 adults receiving chiropractic spinal manipulation for radicular LBP receive significantly less gabapentin prescription (OR 0.53; 0.40 to 0.71; p<0.0001) over 1-year follow-up compared with those receiving usual medical care https://t.co/t0uTMdLEzO https://t.co/rCR04sMdRV
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
JAMA: cutaneous hallmarks of dermatomyositis. Printable Patient education overview. https://t.co/VKsxT34lga https://t.co/VGaFmsYUrP
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Bringing pivotal clinical trials to you: announcing RheumNow’s Poster Hall, featuring previously presented, sponsor-generated clinical trial posters designed to educate and inform.
https://t.co/GvX0lcCng6 https://t.co/IUfkj4emim
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
MMWR: Arthritis Among Children and Adolescents
The CDC estimates that nearly 220,000 children and adolescents had arthritis during 2017–2021.
https://t.co/pQnB3zV7sw https://t.co/nrLZ8Uazgh
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
NEJM: 19 yoM w/ 3yr hx of Raynauds, periungual erythema. Nailfold capillaroscopy showed giant nailfold capillaries, branched & bushy neovascularized capillary loops & reduced capillary density; suggesting clinically amyopathic dermatomyositis https://t.co/Wvnp7wCajx
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
Double blind RCT of 101 active AS patients with BASDAI ≥4 showed the IL-23 inhibitor, tildrakizumab was not superior to placebo after 24 weeks (ASAS20: 74% on tildrakizumab 200 mg vs 80% on PBO). Study was terminated after wk 24 interim analysis https://t.co/zZxiAk6A5o https://t.co/P1tNX8BN6C
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 7 months ago
